• Mashup Score: 4

    Striking out non-Hodgkin Lymphoma Non-Hodgkin Lymphoma Dimas’s Story Dimas has been following his dreams his entire life. As a child, he wanted to be a professional baseball player. He worked hard and was drafted by the LA Dodgers as a pitcher. After a rotator cuff injury ended his professional baseball career, he…

    Tweet Tweets with this article
    • After being diagnosed with #NonHodgkinLymphoma, Dimas became an advocate to share his inspirational story and spread hope. @CRISPRTX is grateful for people like Dimas and we are privileged to share his story. Read more here: https://t.co/tqDuqtfgug https://t.co/itK77qNQ2m

  • Mashup Score: 0

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • We had the chance at #COSTEM22 to talk to @albertomussetti (@hhospitalet) on allogeneic SCT post #CART in #NonHodgkinLymphoma! Keep an eye out on https://t.co/O9p0vDjQaW for our exclusive interview with him💻 @COSTEMCongress #LYMsm #ImmunoOnc #tcellrx #NHLsm https://t.co/kbSts14OH8

  • Mashup Score: 1
    Newsletter | VJHemOnc - 2 year(s) ago

    Email * Institute/Organization * Country * VJHemOnc is intended for Healthcare Professionals onlyWhat is your primary role? * Please select the areas you are interested in: All DiseasesLeukemiasLymphomasMultiple MyelomaMPNsMDSOther DiseasesVJHemOnc uses the above contact information to keep you up to date with our latest hemonc news and videos. Emails and website content are sometimes supported…

    Tweet Tweets with this article
    • CD20-directed #CART therapy in #Lymphoma w/ @mshadman (@fredhutch) Stay updated with all presentations & discussions from #iwNHL22 ➡️https://t.co/8kJeY0Tf6s⬅️ #HemOnc #LYMsm #NonHodgkinLymphoma #ImmunoOnc #tcellrx https://t.co/A90ZyDvL0J

  • Mashup Score: 0
    Newsletter | VJHemOnc - 2 year(s) ago

    Email * Institute/Organization * Country * VJHemOnc is intended for Healthcare Professionals onlyWhat is your primary role? * Please select the areas you are interested in: All DiseasesLeukemiasLymphomasMultiple MyelomaMPNsMDSOther DiseasesVJHemOnc uses the above contact information to keep you up to date with our latest hemonc news and videos. Emails and website content are sometimes supported…

    Tweet Tweets with this article
    • TG-1801-based therapy w/ @gaelroueBCN (@CarrerasIJC) Click here to receive the latest updates on all the presentations from #iwNHL22 👉https://t.co/yX0ki6f5mE👈 #HemOnc #LYMsm #Lymphoma #NonHodgkinLymphoma #ImmunoOnc https://t.co/BRmdRD9Pas

  • Mashup Score: 0

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • It's great to finally be able to have in-person interactive discussions! 🎥 Presentations will be available to view on demand on https://t.co/O9p0vDBrzw Click here to receive the latest updates 👉https://t.co/yX0ki6f5mE👈 #iwNHL22 #HemOnc #LYMsm #Lymphoma #NonHodgkinLymphoma https://t.co/cZTVTlb5QB

  • Mashup Score: 0

    Researchers sought to determine the incidence and possible risk factors of acute kidney injury in patients undergoing a chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.

    Tweet Tweets with this article
    • Researchers characterized the incidence of, and some patterns related to, #acuteKidneyInjury in patients with #nonHodgkinLymphoma after 1 month following chimeric antigen receptor T-cell therapy. They reported their findings in the @MayoProceedings. https://t.co/gv8K2UT0oH

  • Mashup Score: 1

    CAR-T therapy has revolutionized the treatment landscape of several hematological malignancies, and ongoing clinical trials continue to provide valuable data…

    Tweet Tweets with this article
    • 🚨 We've just posted a new podcast on #CART therapy in #Lymphoma & #MultipleMyeloma! 🎧 Listen to it here: 👉https://t.co/BKRVSW44By 👈 @VJHemOnc #iwCART22 #HemOnc #LYMsm #NonHodgkinLymphoma #DLBCL #FollicularLymphoma #MantleCellLymphoma #MMSM #Myeloma #ImmunoOnc #tcellrx

  • Mashup Score: 1

    Over the last few decades, advances in immunotherapies including CAR-T therapy have revolutionized the treatment of patients with relapsed/refractory (R/R)…

    Tweet Tweets with this article
    • 🚨 NEW podcast alert 🚨 🎧 Hear about the current state of #CART therapy in #Lymphoma with leading experts David Maloney, Caron Jacobson & @LNastoupilMD 👉https://t.co/l36HVhn9HJ👈 @VJHemOnc #iwCART22 #HemOnc #ImmunoOnc #tcellrx #NonHodgkinLymphoma #FollicularLymphoma #LYMsm